Please login to the form below
AZ’s Imfinzi gets US OK in small cell lung cancer, challenging Tecentriq
First checkpoint inhibitor to challenge Roche's Tecentriq in this indication
Amarin shares tumble following Vascepa patent loss
Judgement invalidates six key patents on fish-oil derived med
Bayer gets EU nod for prostate cancer drug Nubeqa
Enters an increasingly competitive market
FDA grants emergency authorisation to chloroquine for COVID-19
Novartis and Bayer donate anti-malaria drugs to US stockpile
In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
Monthly meeting held remotely for the first time due to COVID-19 pandemic
Merck gets first approval for MET inhibitor tepotinib in Japan
First worldwide approval for MET inhibitor
UPDATED: Gilead drops remdesivir’s orphan drug designation
Decision comes amid intense public criticism of the regulatory status
FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes
Formally rejects extended use of SGLT2 inhibitor
FDA green lights rapid coronavirus diagnostic test
Test can diagnose positive cases in approximately 45 minutes
‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’
Brexit means pharma must review its intellectual property rights across Europe
-
Moving timesContinuity and stability are vital when it comes to the EMA's relocation when it leaves London
-
SMC gives green light for Amgen’s KyprolisThe committee also gives verdict on three other products
-
FDA maintains COVID-19 therapeutics must meet a ‘gold standard’ Comes after President Trump called for expedited approval of potential treatments
-
Trump calls on FDA to cut ‘red tape’ as coronavirus drug trials gather paceA number of candidates begin trial testing
-
J&J aims for US approval of MS drug ponesimodFiles application with FDA in relapsing form of the disease
-
FDA knocks back DBV’s peanut allergy therapy once againDrug loses further ground to Aimmune's Palforzia
-
NHS England will make PrEP for HIV available in AprilWill be made available to patients at risk of contracting infection
-
FDA green lights study of phage-based drug for resistant infections
Possible alternative to conventional antibiotics
-
FDA okays Roche’s COVID-19 diagnostic testIncreases capacity for testing as coronavirus cases grow
Latest regulatory appointments
-
ABPI appoints industry veteran Richard Torbett as new chief executiveTorbett initially joined the pharma association in March 2016
-
Professor Carole Longson moves from NICE to the ABPIShe joins the UK pharma body as its chief scientific officer
-
MedTech Europe appoints new board of directors
Chair of the board Michelle Brennan is among those newly elected
-
Greg Perry joins IFPMA as assistant director generalWill move to the global industry body from the Medicines Patent Pool
-
AVEO appoints Nikhil Mehta as its senior VP, regulatory and quality assurance
He joins the biopharma from Tang Capital Management
COVID-19 Updates and Daily News
Featured jobs
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
-
Account Director
-
£Competitive Salary
- UK, China prep trials of coronavirus vaccine candidates
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- China backs use of Roche’s Actemra for coronavirus
- Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19
- Novartis donates malaria drug for COVID-19 clinical trials
- Moderna and GSK advance coronavirus vaccine candidates
- Incyte and Novartis join coronavirus efforts with phase 3 study
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- Merck’s Keytruda beats chemo in first-line colorectal cancer
- “Fake News” and Credibility in Medical Publishing
- How Much Does Each Advisor “Insight” Actually Cost?
- It's not just our logo that's green
PMHub
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...
Latest intelligence
- “Fake News” and Credibility in Medical Publishing
- Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
- Pharma funding and M&A in 2020
- Why pharma M&A has continually bucked the trend...
Quick links
Infographics
